CP3 Director Gellad Comments on Pfizer's Price Increases

November 16, 2018

"The drug price pledges made earlier this year were just for show — it was obvious at the time, and it's obvious now," notes CP3 Director Walid Gellad, in a Politico piece about Pfizer's recent price increases. Gellad also commented on the Trump administration's tendency to sharply criticize Drug companies. "The bully pulpit doesn't work, and even if it did, we don't want a system in which the only way to bring down drug prices is for the president to publicly berate a company — that's not a healthy market and not good policy."